Behavioural Intervention
Vestibular Stimulation for Vestibular Hypofunction
Recruiting0 awards3 criteria
Omaha, Nebraska
"This trial aims to investigate the use of subthreshold vestibular stimulation as a new way to improve balance and reduce symptoms for individuals with bilateral vestibular hypofunction. This condition affects over 64,
MK-1167 Period 1 for Healthy Subjects
Recruiting1 awardPhase 1
Lincoln, Nebraska
The goal of this study this study is to learn about the safety of MK-1167 and if people tolerate it. Researchers will compare what happens to MK-1167 in the body when it is given with and without another medicine called diltiazem.
Popular Filters
Phase 3 Trials
Behavioural Intervention
Lumateperone for Autism
Recruiting1 awardPhase 3
Lincoln, Nebraska
This trial is testing a new medication for irritability in children with Autism Spectrum Disorder. It will involve multiple medical centers and the participants will be randomly assigned to receive either the new medication or a placebo.
RNAi Therapeutics
Vutrisiran for Amyloid Cardiomyopathy
Recruiting2 awardsPhase 3
Omaha, Nebraska
This trial aims to gather information on the safety and effectiveness of using vutrisiran in patients with a certain type of heart disease called ATTR amyloidosis. The study will look at patients who either
Trials With No Placebo
Tedizolid Phosphate Oral Formulation 1 (Reference) for Healthy Subjects
Recruiting1 awardPhase 1
Lincoln, Nebraska
The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the absorption and elimination of different oral formulations from the healthy person's body.
Part 1: MK-1084 + Itraconazole for Healthy Subjects
Recruiting1 awardPhase 1
Lincoln, Nebraska
The goal of this study is to learn what happens to MK-1084 in a healthy person's body over time, called a pharmacokinetic (PK) study. Researchers want to compare the amount of MK-1084 when it is taken as a single dose; with multiple doses of itraconazole, or with multiple doses of phenytoin.
Trials Offering Remuneration
Tedizolid Phosphate Oral Formulation 1 (Reference) for Healthy Subjects
Recruiting1 awardPhase 1
Lincoln, Nebraska
The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the absorption and elimination of different oral formulations from the healthy person's body.
Part 1: MK-1084 + Itraconazole for Healthy Subjects
Recruiting1 awardPhase 1
Lincoln, Nebraska
The goal of this study is to learn what happens to MK-1084 in a healthy person's body over time, called a pharmacokinetic (PK) study. Researchers want to compare the amount of MK-1084 when it is taken as a single dose; with multiple doses of itraconazole, or with multiple doses of phenytoin.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.